ライフサイエンスコーパス: showed no

1 Chromatographic determination of EDTA showed no accumulation in the muscle and sensory results demo

2 Hydraulic traits showed no adjustment following 15 years of experimentally imp

3 The IPTW-adjusted analyses showed no association between prenatal Tdap vaccination and A

4 FAC, muscle tone, and power showed no association with HKP.

5 eutrophils, respectively; (2) in contrast, sCD14 and sCD163 showed no association with need for ICU treatment; and (3) le

6 ecrease in dilutions of PZA MIC for PZA susceptible strains showed no association with SCC in crude or adjusted analyses

7 Patients who were untreated showed no change in any FDG PET or cardiac MRI parameter.

8 While tissue homogenate showed no changes in tubulin acetylation between control, dep

9 easures (sway, acceleration, co-contraction, effort, falls) showed no correlation with either FAC or SC.

10 d astrocyte activation, whereas nTg mice with MPTP exposure showed no deficits.

11 However, prostacyclin receptor activated with iloprost showed no detectable voltage dependence.

12 An analysis of a >=2-stage progression in MiToS stage showed no difference between treatment arms during double-bli

13 the Cameroonian forest, but zoo and Cameroonian chimpanzees showed no difference.

14 the fellow eye group, VA, CMT, and all choroidal parameters showed no differences between baseline and any follow-up visi

15 weeks, WT and AIF1L deficient mice gained weight similarly, showed no differences in fat or lean mass accumulation, and d

16 , mtACP2 (At1g65290), and mtACP3 (At5g47630) single mutants showed no discernible morphological growth phenotype.

17 The films showed no DPPH radical scavenging properties but high FRAP (6

18 coherence tomography of Erdj5-/- and P23H+/-:Erdj5-/- mice showed no effect of ERdj5 ablation on retinal function or pho

19 an exercise intervention to a subset of PolgA(mut/mut) mice showed no effect on bone mass or mineralised matrix formation

20 ntibody partially downregulated mTOR pathway activation but showed no effect on viability.

21 However, lower doses of GBP (100 and 200 mg/kg) showed no effect.

22 ChAd-S alone showed no efficacy.

23 Multidisciplinary evaluation of our national cohort showed no evidence for a severe, clinically relevant systemic

24 onstrate that mice lacking IL-17RA, Act1, or interleukin 22 showed no evidence for altered VVC susceptibility or immunopa

25 arison group (10 per 10 000 person-years), adjusted results showed no evidence of any association between the use of glit

26 bour, short interval between membrane rupture and delivery) showed no evidence of association with atopic dermatitis.

27 Also, ultrastructural examination by electron microscopy showed no evidence of viral particles in the biopsy samples.

28 revealed that anti-VEGF treated patients with wet AMD, who showed no exudative signs on the day of blood drawing had a c

29 st brain CT studies requested from the emergency department showed no findings that would modify the management of the pa

30 Although linear mixed effects models showed no FSC from the 12 profiled foods were significantly a

31 However, these imaging features showed no interaction with alteplase dose.

32 ists appeared as openings in quick succession (bursts) that showed no ligand concentration dependence.

33 After reverting this mutation, the enzyme showed no loss in activity compared to wild type, while displ

34 Conversely, four patients who had MYD88(WT) disease showed no major responses.

35 Studies of AIF1L deficient mice showed no obvious postnatal developmental phenotype.

36 2D maps of NLS-GFP recovery times showed no pixel-by-pixel correlation with histone density, al

37 ificantly reduced levels of MUC5AC protein expression, they showed no reduction in the degree of mucus obstruction, MUC5B

38 ith low LS BMD, 48 weeks of alendronate was well-tolerated, showed no safety concerns, and significantly improved LS and

39 In the aMCI group the RLCQ and the PSS showed no significant association with cognitive function at

40 ere dried in 210 min; with higher drying rates, CHD samples showed no significant changes in powder characteristics, colo

41 ma medications did not change in both groups (p > 0.05) and showed no significant difference between the two groups (p >

42 Tissue collected at 7-12 months post-injury showed no significant differences in lesion size, fibrotic sc

43 In contrast, the control group showed no significant differences.

44 Duty hour reform showed no significant effect on 30-day mortality achieved by

45 Finally, VZHE-039 showed no significant inhibition of several CYPs, demonstrate

46 nd methanogenic cultures, whereas nitrate-reducing cultures showed no SMX transformation.

47 eriments detected mcr-9 in under 10 min, and both platforms showed no statistically significant difference (p-value > 0.0

48 CBCT scan analyses showed no statistically significant differences between group

49 The standard slit lamp examination showed no transillumination defects of either iris.

50 Patients not receiving alemtuzumab (n=4) showed no UCART19 expansion or antileukaemic activity.